{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["diabetes", "diabetic neuropathic pain", "diabetic neuropathy", "topical treatments"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "30783472", "DateRevised": {"Year": "2020", "Month": "09", "Day": "29"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "01", "Day": "15"}], "Language": ["eng"], "ELocationID": ["10.3892/etm.2019.7173"], "Journal": {"ISSN": "1792-0981", "JournalIssue": {"Volume": "17", "Issue": "3", "PubDate": {"Year": "2019", "Month": "Mar"}}, "Title": "Experimental and therapeutic medicine", "ISOAbbreviation": "Exp Ther Med"}, "ArticleTitle": "Topical treatments for diabetic neuropathic pain.", "Pagination": {"StartPage": "1963", "EndPage": "1976", "MedlinePgn": "1963-1976"}, "Abstract": {"AbstractText": ["Diabetic neuropathic pain (DNP) has a huge impact on quality of life and can be difficult to treat. Oral treatment is the most frequently used method for DNP, but its use is often limited by systemic side effects. Topical use of drugs as an alternative option for DNP treatment is currently gaining interest. In the present review, a summary is provided of the available agents for topical use in patients with DNP, including lidocaine plasters or patches, capsaicin cream, gel or patches, amitriptyline cream, clonidine gel, ketamine cream, extracts from medicinal plants including nutmeg extracts and <i>Citrullus colocynthis</i> extract oil, and certain compounded topical analgesics. Furthermore, the potential efficacy of these treatments is addressed according to the available clinical research literature. It has been indicated that these topical drugs have the potential to be valuable additional options for the management of DNP, with adequate safety and continuous long-term treatment efficacy. Compounded topical agents are also effective and safe for patients with DNP and could be another area worthy of further investigation based on the strategy of using low-dose, complementary therapies for DNP. The findings indicate that developing topical drugs acting on different targets in the process of DNP is a valuable area of future research."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, P.R. China."}, {"Identifier": [], "Affiliation": "Phase I Clinical Trial Center, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, P.R. China."}], "LastName": "Yang", "ForeName": "Xi-Ding", "Initials": "XD"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, P.R. China."}, {"Identifier": [], "Affiliation": "Phase I Clinical Trial Center, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, P.R. China."}], "LastName": "Fang", "ForeName": "Ping-Fei", "Initials": "PF"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, P.R. China."}, {"Identifier": [], "Affiliation": "Hunan Provincial Engineering Research Center of Translational Medical and Innovative Drug, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, P.R. China."}], "LastName": "Xiang", "ForeName": "Da-Xiong", "Initials": "DX"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, P.R. China."}, {"Identifier": [], "Affiliation": "Hunan Provincial Engineering Research Center of Translational Medical and Innovative Drug, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, P.R. China."}], "LastName": "Yang", "ForeName": "Yong-Yu", "Initials": "YY"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Greece", "MedlineTA": "Exp Ther Med", "NlmUniqueID": "101531947", "ISSNLinking": "1792-0981"}}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "International Diabetes Federation (IDF) IDF Diabetes Atlas. (7th) 2017"}, {"Citation": "Edwards JL, Vincent AM, Cheng HT, Feldman EL. Diabetic neuropathy: Mechanisms to management. Pharmacol Ther. 2008;120:1\u201334. doi: 10.1016/j.pharmthera.2008.05.005.", "ArticleIdList": ["10.1016/j.pharmthera.2008.05.005", "PMC4007052", "18616962"]}, {"Citation": "Harati Y. Diabetic neuropathies: Unanswered questions. Neurol Clin. 2007;25:303\u2013317. doi: 10.1016/j.ncl.2007.01.002.", "ArticleIdList": ["10.1016/j.ncl.2007.01.002", "17324729"]}, {"Citation": "Farmer KL, Li C, Dobrowsky RT. Diabetic peripheral neuropathy: Should a chaperone accompany our therapeutic approach? Pharmacol Rev. 2012;64:880\u2013900. doi: 10.1124/pr.111.005314.", "ArticleIdList": ["10.1124/pr.111.005314", "PMC3462992", "22885705"]}, {"Citation": "Spallone V, Lacerenza M, Rossi A, Sicuteri R, Marchettini P. Painful diabetic polyneuropathy: Approach to diagnosis and management. Clin J Pain. 2012;28:726\u2013743. doi: 10.1097/AJP.0b013e318243075c.", "ArticleIdList": ["10.1097/AJP.0b013e318243075c", "22209797"]}, {"Citation": "Snyder MJ, Gibbs LM, Lindsay TJ. Treating painful diabetic peripheral neuropathy: An update. Am Fam Physician. 2016;94:227\u2013234.", "ArticleIdList": ["27479625"]}, {"Citation": "Schreiber AK, Nones CF, Reis RC, Chichorro JG, Cunha JM. Diabetic neuropathic pain: Physiopathology and treatment. World J Diabetes. 2015;6:432\u2013444. doi: 10.4239/wjd.v6.i3.432.", "ArticleIdList": ["10.4239/wjd.v6.i3.432", "PMC4398900", "25897354"]}, {"Citation": "Tesfaye S, Vileikyte L, Rayman G, Sindrup SH, Perkins BA, Baconja M, Vinik AI, Boulton AJ. Toronto Expert Panel on Diabetic Neuropathy: Painful diabetic peripheral neuropathy: Consensus recommendations on diagnosis, assessment and management. Diabetes Metab Res Rev. 2011;27:629\u2013638. doi: 10.1002/dmrr.1225.", "ArticleIdList": ["10.1002/dmrr.1225", "21695762"]}, {"Citation": "Jane SW, Lin MS, Chiu WN, Beaton RD, Chen MY. Prevalence, discomfort and self-relief behaviours of painful diabetic neuropathy in Taiwan: A cross-sectional study. BMJ Open. 2016;6:e11897. doi: 10.1136/bmjopen-2016-011897.", "ArticleIdList": ["10.1136/bmjopen-2016-011897", "PMC5073541", "27697870"]}, {"Citation": "Tesfaye S, Boulton AJ, Dickenson AH. Mechanisms and management of diabetic painful distal symmetrical polyneuropathy. Diabetes Care. 2013;36:2456\u20132465. doi: 10.2337/dc12-1964.", "ArticleIdList": ["10.2337/dc12-1964", "PMC3747929", "23970715"]}, {"Citation": "Gore M, Brandenburg NA, Dukes E, Hoffman DL, Tai KS, Stacey B. Pain severity in diabetic peripheral neuropathy is associated with patient functioning, symptom levels of anxiety and depression, and sleep. J Pain Symptom Manage. 2005;30:374\u2013385. doi: 10.1016/j.jpainsymman.2005.04.009.", "ArticleIdList": ["10.1016/j.jpainsymman.2005.04.009", "16256902"]}, {"Citation": "Vileikyte L, Leventhal H, Gonzalez JS, Peyrot M, Rubin RR, Ulbrecht JS, Garrow A, Waterman C, Cavanagh PR, Boulton AJ. Diabetic peripheral neuropathy and depressive symptoms: The association revisited. Diabetes Care. 2005;28:2378\u20132383. doi: 10.2337/diacare.28.10.2378.", "ArticleIdList": ["10.2337/diacare.28.10.2378", "16186266"]}, {"Citation": "Sadosky A, McDermott AM, Brandenburg NA, Strauss M. A review of the epidemiology of painful diabetic peripheral neuropathy, postherpetic neuralgia, and less commonly studied neuropathic pain conditions. Pain Pract. 2008;8:45\u201356. doi: 10.1111/j.1533-2500.2007.00164.x.", "ArticleIdList": ["10.1111/j.1533-2500.2007.00164.x", "18211592"]}, {"Citation": "Ziegler D. Painful diabetic neuropathy: Treatment and future aspects. Diabetes Metab Res Rev. 2008;24(Suppl 1):S52\u2013S57. doi: 10.1002/dmrr.817.", "ArticleIdList": ["10.1002/dmrr.817", "18395890"]}, {"Citation": "Kaku M, Vinik A, Simpson DM. Pathways in the diagnosis and management of diabetic polyneuropathy. Curr Diab Rep. 2015;15:609. doi: 10.1007/s11892-015-0609-2.", "ArticleIdList": ["10.1007/s11892-015-0609-2", "PMC4440893", "25899758"]}, {"Citation": "Sawynok J, Zinger C. Topical amitriptyline and ketamine for post-herpetic neuralgia and other forms of neuropathic pain. Expert Opin Pharmacother. 2016;17:601\u2013609. doi: 10.1517/14656566.2016.1146691.", "ArticleIdList": ["10.1517/14656566.2016.1146691", "26809783"]}, {"Citation": "Ziegler D, Fonseca V. From guideline to patient: A review of recent recommendations for pharmacotherapy of painful diabetic neuropathy. J Diabetes Complications. 2015;29:146\u2013156. doi: 10.1016/j.jdiacomp.2014.08.008.", "ArticleIdList": ["10.1016/j.jdiacomp.2014.08.008", "25239450"]}, {"Citation": "van Nooten F, Treur M, Pantiri K, Stoker M, Charokopou M. Capsaicin 8% patch versus oral neuropathic pain medications for the treatment of painful diabetic peripheral neuropathy: A systematic literature review and network meta-analysis. Clin Ther. 2017;39:787\u2013803.e18. doi: 10.1016/j.clinthera.2017.02.010.", "ArticleIdList": ["10.1016/j.clinthera.2017.02.010", "28365034"]}, {"Citation": "Argoff CE. Topical analgesics in the management of acute and chronic pain. Mayo Clin Proc. 2013;88:195\u2013205. doi: 10.1016/j.mayocp.2012.11.015.", "ArticleIdList": ["10.1016/j.mayocp.2012.11.015", "23374622"]}, {"Citation": "Jorge LL, Feres CC, Teles VE. Topical preparations for pain relief: Efficacy and patient adherence. J Pain Res. 2010;4:11\u201324. doi: 10.2147/JPR.S9492.", "ArticleIdList": ["10.2147/JPR.S9492", "PMC3048583", "21386951"]}, {"Citation": "Derry S, Rice AS, Cole P, Tan T, Moore RA. Topical capsaicin (high concentration) for chronic neuropathic pain in adults. Cochrane Database Syst Rev. 2017;1:CD007393.", "ArticleIdList": ["PMC6464756", "28085183"]}, {"Citation": "Mick G, Correa-Illanes G. Topical pain management with the 5% lidocaine medicated plaster-a review. Curr Med Res Opin. 2012;28:937\u2013951. doi: 10.1185/03007995.2012.690339.", "ArticleIdList": ["10.1185/03007995.2012.690339", "22551228"]}, {"Citation": "Mou J, Paillard F, Turnbull B, Trudeau J, Stoker M, Katz NP. Qutenza (capsaicin) 8% patch onset and duration of response and effects of multiple treatments in neuropathic pain patients. Clin J Pain. 2014;30:286\u2013294. doi: 10.1097/AJP.0b013e31829a4ced.", "ArticleIdList": ["10.1097/AJP.0b013e31829a4ced", "23765045"]}, {"Citation": "Kiani J, Ahmad Nasrollahi S, Esna-Ashari F, Fallah P, Sajedi F. Amitriptyline 2% cream vs. capsaicin 0.75% cream in the treatment of painful diabetic neuropathy (Double blind, randomized clinical trial of efficacy and safety) Iran J Pharm Res. 2015;14:1263\u20131268.", "ArticleIdList": ["PMC4673956", "26664395"]}, {"Citation": "Wrzosek A, Woron J, Dobrogowski J, Jakowicka-Wordliczek J, Wordliczek J. Topical clonidine for neuropathic pain. Cochrane Database Syst Rev. 2015;8:CD010967.", "ArticleIdList": ["PMC6489438", "26329307"]}, {"Citation": "Motilal S, Maharaj RG. Nutmeg extracts for painful diabetic neuropathy: A randomized, double-blind, controlled study. J Altern Complement Med. 2013;19:347\u2013352. doi: 10.1089/acm.2012.0016.", "ArticleIdList": ["10.1089/acm.2012.0016", "23098698"]}, {"Citation": "Heydari M, Homayouni K, Hashempur MH, Shams M. Topical Citrullus colocynthis (bitter apple) extract oil in painful diabetic neuropathy: A double-blind randomized placebo-controlled clinical trial. J Diabetes. 2016;8:246\u2013252. doi: 10.1111/1753-0407.12287.", "ArticleIdList": ["10.1111/1753-0407.12287", "25800045"]}, {"Citation": "A study of the efficacy and safety of amitriptyline/ketamine topical cream in patients with diabetic peripheral neuropathy. ClinicalTrials.gov. 2006 NCT00476151."}, {"Citation": "Casale R, Symeonidou Z, Bartolo M. Topical treatments for localized neuropathic pain. Curr Pain Headache Rep. 2017;21:15. doi: 10.1007/s11916-017-0615-y.", "ArticleIdList": ["10.1007/s11916-017-0615-y", "PMC5340828", "28271334"]}, {"Citation": "Sloan G, Shillo P, Selvarajah D, Wu J, Wilkinson ID, Tracey I, Anand P, Tesfaye S. A new look at painful diabetic neuropathy. Diabetes Res Clin Pract. 2018;144:177\u2013191. doi: 10.1016/j.diabres.2018.08.020.", "ArticleIdList": ["10.1016/j.diabres.2018.08.020", "30201394"]}, {"Citation": "Dewanjee S, Das S, Das AK, Bhattacharjee N, Dihingia A, Dua TK, Kalita J, Manna P. Molecular mechanism of diabetic neuropathy and its pharmacotherapeutic targets. Eur J Pharmacol. 2018;833:472\u2013523. doi: 10.1016/j.ejphar.2018.06.034.", "ArticleIdList": ["10.1016/j.ejphar.2018.06.034", "29966615"]}, {"Citation": "Dobretsov M, Hastings SL, Romanovsky D, Stimers JR, Zhang JM. Mechanical hyperalgesia in rat models of systemic and local hyperglycemia. Brain Res. 2003;960:174\u2013183. doi: 10.1016/S0006-8993(02)03828-3.", "ArticleIdList": ["10.1016/S0006-8993(02)03828-3", "12505670"]}, {"Citation": "Oyibo SO, Prasad YD, Jackson NJ, Jude EB, Boulton AJ. The relationship between blood glucose excursions and painful diabetic peripheral neuropathy: A pilot study. Diabet Med. 2002;19:870\u2013873. doi: 10.1046/j.1464-5491.2002.00801.x.", "ArticleIdList": ["10.1046/j.1464-5491.2002.00801.x", "12358878"]}, {"Citation": "Morley GK, Mooradian AD, Levine AS, Morley JE. Mechanism of pain in diabetic peripheral neuropathy. Effect of glucose on pain perception in humans. Am J Med. 1984;77:79\u201382. doi: 10.1016/0002-9343(84)90439-X.", "ArticleIdList": ["10.1016/0002-9343(84)90439-X", "6741987"]}, {"Citation": "Lee JH, Cox DJ, Mook DG, McCarty RC. Effect of hyperglycemia on pain threshold in alloxan-diabetic rats. Pain. 1990;40:105\u2013107. doi: 10.1016/0304-3959(90)91057-P.", "ArticleIdList": ["10.1016/0304-3959(90)91057-P", "2339005"]}, {"Citation": "Dyck PJ, Litchy WJ, Lehman KA, Hokanson JL, Low PA, O'Brien PC. Variables influencing neuropathic endpoints: The rochester diabetic neuropathy study of healthy subjects. Neurology. 1995;45:1115\u20131121. doi: 10.1212/WNL.45.6.1115.", "ArticleIdList": ["10.1212/WNL.45.6.1115", "7783874"]}, {"Citation": "Romanovsky D, Wang J, Al-Chaer ED, Stimers JR, Dobretsov M. Comparison of metabolic and neuropathy profiles of rats with streptozotocin-induced overt and moderate insulinopenia. Neuroscience. 2010;170:337\u2013347. doi: 10.1016/j.neuroscience.2010.06.059.", "ArticleIdList": ["10.1016/j.neuroscience.2010.06.059", "PMC2926213", "20600635"]}, {"Citation": "Peppa M, Stavroulakis P, Raptis SA. Advanced glycoxidation products and impaired diabetic wound healing. Wound Repair Regen. 2009;17:461\u2013472. doi: 10.1111/j.1524-475X.2009.00518.x.", "ArticleIdList": ["10.1111/j.1524-475X.2009.00518.x", "19614910"]}, {"Citation": "Babizhayev MA, Strokov IA, Nosikov VV, Savel'Yeva EL, Sitnikov VF, Yegorov YE, Lankin VZ. The role of oxidative stress in diabetic neuropathy: Generation of free radical species in the glycation reaction and gene polymorphisms encoding antioxidant enzymes to genetic susceptibility to diabetic neuropathy in population of type i diabetic patients. Cell Biochem Biophys. 2015;71:1425\u20131443. doi: 10.1007/s12013-014-0365-y.", "ArticleIdList": ["10.1007/s12013-014-0365-y", "25427889"]}, {"Citation": "Oates PJ. Polyol pathway and diabetic peripheral neuropathy. Int Rev Neurobiol. 2002;50:325\u2013392. doi: 10.1016/S0074-7742(02)50082-9.", "ArticleIdList": ["10.1016/S0074-7742(02)50082-9", "12198816"]}, {"Citation": "Obrosova IG. How does glucose generate oxidative stress in peripheral nerve Int Rev Neurobiol. 2002;50:3\u201335.", "ArticleIdList": ["12198815"]}, {"Citation": "Obrosova IG. Diabetes and the peripheral nerve. Biochim Biophys Acta. 2009;1792:931\u2013940. doi: 10.1016/j.bbadis.2008.11.005.", "ArticleIdList": ["10.1016/j.bbadis.2008.11.005", "19061951"]}, {"Citation": "Schemmel KE, Padiyara RS, D'Souza JJ. Aldose reductase inhibitors in the treatment of diabetic peripheral neuropathy: A review. J Diabetes Complications. 2010;24:354\u2013360. doi: 10.1016/j.jdiacomp.2009.07.005.", "ArticleIdList": ["10.1016/j.jdiacomp.2009.07.005", "19748287"]}, {"Citation": "Fuchs D, Birklein F, Reeh PW, Sauer SK. Sensitized peripheral nociception in experimental diabetes of the rat. Pain. 2010;151:496\u2013505. doi: 10.1016/j.pain.2010.08.010.", "ArticleIdList": ["10.1016/j.pain.2010.08.010", "20832942"]}, {"Citation": "Bachewal P, Gundu C, Yerra VG, Kalvala AK, Areti A, Kumar A. Morin exerts neuroprotection via attenuation of ROS induced oxidative damage and neuroinflammation in experimental diabetic neuropathy. Biofactors. 2018;44:109\u2013122. doi: 10.1002/biof.1397.", "ArticleIdList": ["10.1002/biof.1397", "29193444"]}, {"Citation": "Tobon-Velasco JC, Cuevas E, Torres-Ramos MA. Receptor for AGEs (RAGE) as mediator of NF-kB pathway activation in neuroinflammation and oxidative stress. CNS Neurol Disord Drug Targets. 2014;13:1615\u20131626. doi: 10.2174/1871527313666140806144831.", "ArticleIdList": ["10.2174/1871527313666140806144831", "25106630"]}, {"Citation": "Gao X, Wu B, Fu Z, Zhang Z, Xu G. Carvedilol abrogates hypoxia-induced oxidative stress and neuroinflammation in microglial BV2 cells. Eur J Pharmacol. 2017;814:144\u2013150. doi: 10.1016/j.ejphar.2017.08.013.", "ArticleIdList": ["10.1016/j.ejphar.2017.08.013", "28821450"]}, {"Citation": "Dworkin RH. An overview of neuropathic pain: Syndromes, symptoms, signs, and several mechanisms. Clin J Pain. 2002;18:343\u2013349. doi: 10.1097/00002508-200211000-00001.", "ArticleIdList": ["10.1097/00002508-200211000-00001", "12441827"]}, {"Citation": "Djouhri L, Fang X, Koutsikou S, Lawson SN. Partial nerve injury induces electrophysiological changes in conducting (uninjured) nociceptive and nonnociceptive DRG neurons: Possible relationships to aspects of peripheral neuropathic pain and paresthesias. Pain. 2012;153:1824\u20131836. doi: 10.1016/j.pain.2012.04.019.", "ArticleIdList": ["10.1016/j.pain.2012.04.019", "PMC3425771", "22721911"]}, {"Citation": "Aslam A, Singh J, Rajbhandari S. Pathogenesis of painful diabetic neuropathy. Pain Res Treat. 2014;2014:412041.", "ArticleIdList": ["PMC4026988", "24891949"]}, {"Citation": "Rahman MH, Jha MK, Suk K. Evolving insights into the pathophysiology of diabetic neuropathy: Implications of malfunctioning glia and discovery of novel therapeutic targets. Curr Pharm Des. 2016;22:738\u2013757. doi: 10.2174/1381612822666151204001234.", "ArticleIdList": ["10.2174/1381612822666151204001234", "26635266"]}, {"Citation": "Baron R, Mayoral V, Leijon G, Binder A, Steigerwald I, Serpell M. 5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: An open-label, non-inferiority two-stage RCT study. Curr Med Res Opin. 2009;25:1663\u20131676. doi: 10.1185/03007990903047880.", "ArticleIdList": ["10.1185/03007990903047880", "19485723"]}, {"Citation": "Krumova EK, Zeller M, Westermann A, Maier C. Lidocaine patch (5%) produces a selective, but incomplete block of A\u03b4 and C fibers. Pain. 2012;153:273\u2013280. doi: 10.1016/j.pain.2011.08.020.", "ArticleIdList": ["10.1016/j.pain.2011.08.020", "21995882"]}, {"Citation": "Herrmann DN, Barbano RL, Hart-Gouleau S, Pennella-Vaughan J, Dworkin RH. An open-label study of the lidocaine patch 5% in painful idiopathic sensory polyneuropathy. Pain Med. 2005;6:379\u2013384. doi: 10.1111/j.1526-4637.2005.00058.x.", "ArticleIdList": ["10.1111/j.1526-4637.2005.00058.x", "16266359"]}, {"Citation": "Argoff CE, Galer BS, Jensen MP, Oleka N, Gammaitoni AR. Effectiveness of the lidocaine patch 5% on pain qualities in three chronic pain states: Assessment with the neuropathic pain scale. Curr Med Res Opin. 2004;20(Suppl 2):S21\u2013S28. doi: 10.1185/030079904X12979.", "ArticleIdList": ["10.1185/030079904X12979", "15563743"]}, {"Citation": "Barbano RL, Herrmann DN, Hart-Gouleau S, Pennella-Vaughan J, Lodewick PA, Dworkin RH. Effectiveness, tolerability, and impact on quality of life of the 5% lidocaine patch in diabetic polyneuropathy. Arch Neurol. 2004;61:914\u2013918. doi: 10.1001/archneur.61.6.914.", "ArticleIdList": ["10.1001/archneur.61.6.914", "15210530"]}, {"Citation": "Devers A, Galer BS. Topical lidocaine patch relieves a variety of neuropathic pain conditions: An open-label study. Clin J Pain. 2000;16:205\u2013208. doi: 10.1097/00002508-200009000-00005.", "ArticleIdList": ["10.1097/00002508-200009000-00005", "11014393"]}, {"Citation": "Wolff RF, Bala MM, Westwood M, Kessels AG, Kleijnen J. 5% lidocaine medicated plaster in painful diabetic peripheral neuropathy (DPN): A systematic review. Swiss Med Wkly. 2010;140:297\u2013306.", "ArticleIdList": ["20458651"]}, {"Citation": "Baron R, Mayoral V, Leijon G, Binder A, Steigerwald I, Serpell M. Efficacy and safety of 5% lidocaine (lignocaine) medicated plaster in comparison with pregabalin in patients with postherpetic neuralgia and diabetic polyneuropathy: Interim analysis from an open-label, two-stage adaptive, randomized, controlled trial. Clin Drug Investig. 2009;29:231\u2013241. doi: 10.2165/00044011-200929040-00002.", "ArticleIdList": ["10.2165/00044011-200929040-00002", "19301937"]}, {"Citation": "Baron R, Mayoral V, Leijon G, Binder A, Steigerwald I, Serpell M. Efficacy and safety of combination therapy with 5% lidocaine medicated plaster and pregabalin in post-herpetic neuralgia and diabetic polyneuropathy. Curr Med Res Opin. 2009;25:1677\u20131687. doi: 10.1185/03007990903047880.", "ArticleIdList": ["10.1185/03007990903047880", "19480610"]}, {"Citation": "White WT, Patel N, Drass M, Nalamachu S. Lidocaine patch 5% with systemic analgesics such as gabapentin: A rational polypharmacy approach for the treatment of chronic pain. Pain Med. 2003;4:321\u2013330. doi: 10.1111/j.1526-4637.2003.03045.x.", "ArticleIdList": ["10.1111/j.1526-4637.2003.03045.x", "14750908"]}, {"Citation": "Ho KY, Huh BK, White WD, Yeh CC, Miller EJ. Topical amitriptyline versus lidocaine in the treatment of neuropathic pain. Clin J Pain. 2008;24:51\u201355. doi: 10.1097/AJP.0b013e318156db26.", "ArticleIdList": ["10.1097/AJP.0b013e318156db26", "18180637"]}, {"Citation": "Zheng J, Zheng S, Feng Q, Zhang Q, Xiao X. Dietary capsaicin and its anti-obesity potency: From mechanism to clinical implications. Biosci Rep. 2017;37(pii) BSR20170286.", "ArticleIdList": ["PMC5426284", "28424369"]}, {"Citation": "Musharraf MU, Ahmad Z, Yaqub Z. Comparison of topical capsaicin and topical turpentine Oil for treatment of painful diabetic neuropathy. J Ayub Med Coll Abbottabad. 2017;29:384\u2013387.", "ArticleIdList": ["29076666"]}, {"Citation": "Mitchell K, Bates BD, Keller JM, Lopez M, Scholl L, Navarro J, Madian N, Haspel G, Nemenov MI, Iadarola MJ. Ablation of rat TRPV1-expressing Adelta/C-fibers with resiniferatoxin: Analysis of withdrawal behaviors, recovery of function and molecular correlates. Mol Pain. 2010;6:94. doi: 10.1186/1744-8069-6-94.", "ArticleIdList": ["10.1186/1744-8069-6-94", "PMC3019206", "21167052"]}, {"Citation": "Fattori V, Hohmann MS, Rossaneis AC, Pinho-Ribeiro FA, Verri WA. Capsaicin: Current understanding of its mechanisms and therapy of pain and other pre-clinical and clinical uses. Molecules. 2016;21(pii):E844. doi: 10.3390/molecules21070844.", "ArticleIdList": ["10.3390/molecules21070844", "PMC6273101", "27367653"]}, {"Citation": "What role for capsaicin in diabetic peripheral neuropathy? Drug Ther Bull. 2016;54:90\u201393. doi: 10.1136/dtb.2016.8.0417.", "ArticleIdList": ["10.1136/dtb.2016.8.0417", "27516167"]}, {"Citation": "Rosenberg CJ, Watson JC. Treatment of painful diabetic peripheral neuropathy. Prosthet Orthot Int. 2015;39:17\u201328. doi: 10.1177/0309364614542266.", "ArticleIdList": ["10.1177/0309364614542266", "25614498"]}, {"Citation": "Treatment of painful diabetic neuropathy with topical capsaicin. A multicenter, double-blind, vehicle-controlled study. The Capsaicin Study Group. Arch Intern Med. 1991;151:2225\u20132229. doi: 10.1001/archinte.1991.00400110079017.", "ArticleIdList": ["10.1001/archinte.1991.00400110079017", "1953227"]}, {"Citation": "Effect of treatment with capsaicin on daily activities of patients with painful diabetic neuropathy. The Capsaicin Study Group. Diabetes Care. 1992;15:159\u2013165. doi: 10.2337/diacare.15.2.159.", "ArticleIdList": ["10.2337/diacare.15.2.159", "1547671"]}, {"Citation": "Biesbroeck R, Bril V, Hollander P, Kabadi U, Schwartz S, Singh SP, Ward WK, Bernstein JE. A double-blind comparison of topical capsaicin and oral amitriptyline in painful diabetic neuropathy. Adv Ther. 1995;12:111\u2013120.", "ArticleIdList": ["10150323"]}, {"Citation": "Tandan R, Lewis GA, Badger GB, Fries TJ. Topical capsaicin in painful diabetic neuropathy. Effect on sensory function. Diabetes Care. 1992;15:15\u201318. doi: 10.2337/diacare.15.1.8.", "ArticleIdList": ["10.2337/diacare.15.1.8", "1737537"]}, {"Citation": "Tandan R, Lewis GA, Krusinski PB, Badger GB, Fries TJ. Topical capsaicin in painful diabetic neuropathy. Controlled study with long-term follow-up. Diabetes Care. 1992;15:8\u201314. doi: 10.2337/diacare.15.1.8.", "ArticleIdList": ["10.2337/diacare.15.1.8", "1737545"]}, {"Citation": "Chad DA, Aronin N, Lundstrom R, McKeon P, Ross D, Molitch M, Schipper HM, Stall G, Dyess E, Tarsy D. Does capsaicin relieve the pain of diabetic neuropathy? Pain. 1990;42:387\u2013388. doi: 10.1016/0304-3959(90)91153-A.", "ArticleIdList": ["10.1016/0304-3959(90)91153-A", "1701234"]}, {"Citation": "Kulkantrakorn K, Lorsuwansiri C, Meesawatsom P. 0.025% capsaicin gel for the treatment of painful diabetic neuropathy: A randomized, double-blind, crossover, placebo-controlled trial. Pain Pract. 2013;13:497\u2013503. doi: 10.1111/papr.12013.", "ArticleIdList": ["10.1111/papr.12013", "23228119"]}, {"Citation": "Simpson DM, Robinson-Papp J, Van J, Stoker M, Jacobs H, Snijder RJ, Schregardus DS, Long SK, Lambourg B, Katz N. Capsaicin 8% patch in painful diabetic peripheral neuropathy: A randomized, double-blind, placebo-controlled study. J Pain. 2017;18:42\u201353. doi: 10.1016/j.jpain.2016.09.008.", "ArticleIdList": ["10.1016/j.jpain.2016.09.008", "27746370"]}, {"Citation": "Vinik AI, Perrot S, Vinik EJ, Pazdera L, Jacobs H, Stoker M, Long SK, Snijder RJ, van der Stoep M, Ortega E, Katz N. Capsaicin 8% patch repeat treatment plus standard of care (SOC) versus SOC alone in painful diabetic peripheral neuropathy: A randomised, 52-week, open-label, safety study. BMC Neurol. 2016;16:251. doi: 10.1186/s12883-016-0752-7.", "ArticleIdList": ["10.1186/s12883-016-0752-7", "PMC5139122", "27919222"]}, {"Citation": "Bril V, England J, Franklin GM, Backonja M, Cohen J, Del Toro D, Feldman E, Iverson DJ, Perkins B, Russell JW, et al. Evidence-based guideline: Treatment of painful diabetic neuropathy: Report of the American academy of neurology, the American association of neuromuscular and electrodiagnostic medicine and the American academy of physical medicine and rehabilitation. PM R. 2011;3:345\u2013352. doi: 10.1016/j.pmrj.2011.03.008.", "ArticleIdList": ["10.1016/j.pmrj.2011.03.008", "21497321"]}, {"Citation": "Pancrazio JJ, Kamatchi GL, Roscoe AK, Lynch CR III. Inhibition of neuronal Na+ channels by antidepressant drugs. J Pharmacol Exp Ther. 1998;284:208\u2013214.", "ArticleIdList": ["9435180"]}, {"Citation": "Nicholson GM, Blanche T, Mansfield K, Tran Y. Differential blockade of neuronal voltage-gated Na(+) and K(+) channels by antidepressant drugs. Eur J Pharmacol. 2002;452:35\u201348. doi: 10.1016/S0014-2999(02)02239-2.", "ArticleIdList": ["10.1016/S0014-2999(02)02239-2", "12323383"]}, {"Citation": "Joshi PG, Singh A, Ravichandra B. High concentrations of tricyclic antidepressants increase intracellular Ca2+ in cultured neural cells. Neurochem Res. 1999;24:391\u2013398. doi: 10.1023/A:1020937717260.", "ArticleIdList": ["10.1023/A:1020937717260", "10215513"]}, {"Citation": "Watson CP. The treatment of neuropathic pain: Antidepressants and opioids. Clin J Pain. 2000;16(2 Suppl):S49\u2013S55. doi: 10.1097/00002508-200006001-00009.", "ArticleIdList": ["10.1097/00002508-200006001-00009", "10870740"]}, {"Citation": "Kopsky DJ, Hesselink JM. High doses of topical amitriptyline in neuropathic pain: Two cases and literature review. Pain Pract. 2012;12:148\u2013153. doi: 10.1111/j.1533-2500.2011.00477.x.", "ArticleIdList": ["10.1111/j.1533-2500.2011.00477.x", "21676162"]}, {"Citation": "Zeraatian S, Zakeri H, Boroojeny SB, Hourang MH, Ghaffarpasand F, Fard MM. Effect of oral clonidine on acute intraocular pressure rise after phacoemulsification: A prospective double-blind, randomized, clinical trial. J Ocul Pharmacol Ther. 2011;27:293\u2013297. doi: 10.1089/jop.2010.0154.", "ArticleIdList": ["10.1089/jop.2010.0154", "21491994"]}, {"Citation": "Otasowie J, Castells X, Ehimare UP, Smith CH. Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents. Cochrane Database Syst Rev. 2014;9:CD006997.", "ArticleIdList": ["25238582"]}, {"Citation": "Sawynok J. Topical analgesics for neuropathic pain: Preclinical exploration, clinical validation, future development. Eur J Pain. 2014;18:465\u2013481. doi: 10.1002/j.1532-2149.2013.00400.x.", "ArticleIdList": ["10.1002/j.1532-2149.2013.00400.x", "24108446"]}, {"Citation": "Campbell C, Campbell J, Schmidt W, Brady K, Stouch B. Topical clonidine gel reduces pain caused by diabetic neuropathy: Results of a multicenter, placebo-controlled clinical trial. J Pain. 2009;10(Suppl):S55. doi: 10.1016/j.jpain.2009.01.293.", "ArticleIdList": ["10.1016/j.jpain.2009.01.293"]}, {"Citation": "Campbell CM, Kipnes MS, Stouch BC, Brady KL, Kelly M, Schmidt WK, Petersen KL, Rowbotham MC, Campbell JN. Randomized control trial of topical clonidine for treatment of painful diabetic neuropathy. Pain. 2012;153:1815\u20131823. doi: 10.1016/j.pain.2012.04.014.", "ArticleIdList": ["10.1016/j.pain.2012.04.014", "PMC3413770", "22683276"]}, {"Citation": "Grover JK, Khandkar S, Vats V, Dhunnoo Y, Das D. Pharmacological studies on myristica fragrans-antidiarrheal, hypnotic, analgesic and hemodynamic (blood pressure) parameters. Methods Find Exp Clin Pharmacol. 2002;24:675\u2013680. doi: 10.1358/mf.2002.24.10.802317.", "ArticleIdList": ["10.1358/mf.2002.24.10.802317", "12616960"]}, {"Citation": "Hayfaa AA, Sahar AM, Awatif MA. Evaluation of analgesic activity and toxicity of alkaloids in myristica fragrans seeds in mice. J Pain Res. 2013;6:611\u2013615. doi: 10.2147/JPR.S45591.", "ArticleIdList": ["10.2147/JPR.S45591", "PMC3738253", "23946667"]}, {"Citation": "Forouzanfar F, Hosseinzadeh H. Medicinal herbs in the treatment of neuropathic pain: A review. Iran J Basic Med Sci. 2018;21:347\u2013358.", "ArticleIdList": ["PMC5960749", "29796216"]}, {"Citation": "Ramanathan T, Gurudeeban S, Satyavani K. Local anesthetic effect of citrullus colocynthis on rana hexadactyla. Res J Med Plant. 2011;5:338\u2013342. doi: 10.3923/rjmp.2011.338.342.", "ArticleIdList": ["10.3923/rjmp.2011.338.342"]}, {"Citation": "Kumar S, Kumar D, Manjusha, Saroha K, Singh N, Vashishta B. Antioxidant and free radical scavenging potential of citrullus colocynthis (L.) schrad. Methanolic fruit extract. Acta Pharm. 2008;58:215\u2013220. doi: 10.2478/v10007-008-0008-1.", "ArticleIdList": ["10.2478/v10007-008-0008-1", "18515231"]}, {"Citation": "Reddy VP, Sudheshna G, Shaik A, Saran SS, Kumar SN, Ram CR, Reddy KR. Evaluation of antiulcer activity of Citrullus colocynthis fruit against pylorus ligation induced ulcers in male Wistar rats. Int J Pharm Pharm Sci. 2012;4:446\u2013451."}, {"Citation": "Nedjat S, Montazeri A, Holakouie K, Mohammad K, Majdzadeh R. Psychometric properties of the Iranian interview-administered version of the world health organization's quality of life questionnaire (WHOQOL-BREF): A population-based study. BMC Health Serv Res. 2008;8:61. doi: 10.1186/1472-6963-8-61.", "ArticleIdList": ["10.1186/1472-6963-8-61", "PMC2287168", "18366715"]}, {"Citation": "Lynch ME, Clark AJ, Sawynok J, Sullivan MJ. Topical 2% amitriptyline and 1% ketamine in neuropathic pain syndromes: A randomized, double-blind, placebo-controlled trial. Anesthesiology. 2005;103:140\u2013146. doi: 10.1097/00000542-200507000-00021.", "ArticleIdList": ["10.1097/00000542-200507000-00021", "15983466"]}, {"Citation": "Hocking G, Cousins MJ. Ketamine in chronic pain management: An evidence-based review. Anesth Analg. 2003;97:1730\u20131739. doi: 10.1213/01.ANE.0000086618.28845.9B.", "ArticleIdList": ["10.1213/01.ANE.0000086618.28845.9B", "14633551"]}, {"Citation": "Niesters M, Martini C, Dahan A. Ketamine for chronic pain: Risks and benefits. Br J Clin Pharmacol. 2014;77:357\u2013367. doi: 10.1111/bcp.12094.", "ArticleIdList": ["10.1111/bcp.12094", "PMC4014022", "23432384"]}, {"Citation": "Mion G, Villevieille T. Ketamine pharmacology: An update (pharmacodynamics and molecular aspects, recent findings) Cns Neurosci Ther. 2013;19:370\u2013380. doi: 10.1111/cns.12099.", "ArticleIdList": ["10.1111/cns.12099", "PMC6493357", "23575437"]}, {"Citation": "Mahoney JM, Vardaxis V, Moore JL, Hall AM, Haffner KE, Peterson MC. Topical ketamine cream in the treatment of painful diabetic neuropathy: A randomized, placebo-controlled, double-blind initial study. J Am Podiatr Med Assoc. 2012;102:178\u2013183. doi: 10.7547/1020178.", "ArticleIdList": ["10.7547/1020178", "22659759"]}, {"Citation": "Lynch ME, Clark AJ, Sawynok J. A pilot study examining topical amitriptyline, ketamine, and a combination of both in the treatment of neuropathic pain. Clin J Pain. 2003;19:323\u2013328. doi: 10.1097/00002508-200309000-00007.", "ArticleIdList": ["10.1097/00002508-200309000-00007", "12966259"]}, {"Citation": "Lynch ME, Clark AJ, Sawynok J, Sullivan MJ. Topical amitriptyline and ketamine in neuropathic pain syndromes: An open-label study. J Pain. 2005;6:644\u2013649. doi: 10.1016/j.jpain.2005.04.008.", "ArticleIdList": ["10.1016/j.jpain.2005.04.008", "16202956"]}, {"Citation": "Somberg JC, Molnar J. Retrospective study on the analgesic activity of a topical (TT-CTAC) cream in patients with diabetic neuropathy and other chronic pain conditions. Am J Ther. 2015;22:214\u2013221. doi: 10.1097/MJT.0000000000000253.", "ArticleIdList": ["10.1097/MJT.0000000000000253", "25859821"]}, {"Citation": "Javed S, Petropoulos IN, Alam U, Malik RA. Treatment of painful diabetic neuropathy. Ther Adv Chronic Dis. 2015;6:15\u201328. doi: 10.1177/2040622314552071.", "ArticleIdList": ["10.1177/2040622314552071", "PMC4269610", "25553239"]}, {"Citation": "Stanos SP, Galluzzi KE. Topical therapies in the management of chronic pain. Postgrad Med. 2013;125(4 Suppl):S25\u2013S33. doi: 10.1080/00325481.2013.1110567111.", "ArticleIdList": ["10.1080/00325481.2013.1110567111", "24547601"]}, {"Citation": "Barkin RL. The pharmacology of topical analgesics. Postgrad Med. 2013;125(4 Suppl 1):S7\u2013S18. doi: 10.1080/00325481.2013.1110566911.", "ArticleIdList": ["10.1080/00325481.2013.1110566911", "24547599"]}, {"Citation": "Pickering G, Martin E, Tiberghien F, Delorme C, Mick G. Localized neuropathic pain: An expert consensus on local treatments. Drug Des Devel Ther. 2017;11:2709\u20132718. doi: 10.2147/DDDT.S142630.", "ArticleIdList": ["10.2147/DDDT.S142630", "PMC5604568", "29066862"]}]}], "History": [{"Year": "2018", "Month": "6", "Day": "4"}, {"Year": "2018", "Month": "11", "Day": "22"}, {"Year": "2019", "Month": "2", "Day": "21", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "2", "Day": "21", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "2", "Day": "21", "Hour": "6", "Minute": "1"}, {"Year": "2019", "Month": "1", "Day": "15"}], "PublicationStatus": "ppublish", "ArticleIdList": ["30783472", "PMC6364237", "10.3892/etm.2019.7173", "ETM-0-0-7173"]}}]}